The global pharmaceutical contract manufacturing market is anticipated to grow at a considerable CAGR of around 6.9% during the forecast period (2021-2027). The key factor to drive the market growth is the rise in the need for state-of-art methods and production technologies to improve patient outcomes pertaining to various diseases. For instance, in November 2019, South Africa announced that it is going to introduce state-of-the-art known TLD for HIV treatment as almost 20% of the people globally who have HIV live in South Africa. This introduction of the new treatment to have a significant impact on global HIV response and contributes to reaching UN goals for ending the HIV epidemic in 2030.
To Request a Sample of our Report on Pharmaceutical Contract Manufacturing Market: https://www.omrglobal.com/request-sample/pharmaceutical-contract-manufacturing-market
Rising acquisitions, product approval, collaborations among the major players in the market also propel the growth of the market. For instance, in February 2020, Catalent Inc involved in manufacturing and delivering drugs, biologics, cell and gene therapies announced that it has signed an agreement with Zumutor Biologics Inc to manufacture Zumutors ZM008 for the treatment of solid tumours. This agreement Catalent Biologics will provide process optimization and drug substance manufacturing services from its facility site in Madison, Wisconsin. Therefore, with the help of this partnership, Catalent will be supporting Zumutors clinical development and commercial needs by bringing upon improvements in cancer treatments. Further, in December 2019, Thermo Fishers Inc officially opened its latest Viral Vector Contract development and manufacturing organization in Lexington that cost $90 million. This 50,000 sq. ft facility will be supporting, the production, testing and manufacturing of viral vectors that are essential for the advancement of new life-saving gene and cell therapies.
(Get 15% Discount on Buying this Report)
A full Report of Pharmaceutical Contract Manufacturing Market is Available at: https://www.omrglobal.com/industry-reports/pharmaceutical-contract-manufacturing-market
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- ByCategory
- By Type
- By Product
- By Service
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Baxter International Inc, Pfizer Inc., Boehringer Ingelheim International GmbH., Amgen Inc.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Pharmaceutical Contract Manufacturing Market Report Segment
By Category
- Human-Based Drugs
- Animals Based Drugs
By Type
- Sterile Manufacturing
- Non-Sterile Manufacturing
By Product
- Over-The-Counter (OTC) Drugs
- Active Pharmaceutical Ingredients (API)
- Finished Dosage Formulation
- Others (nutritional products and packaging)
By Services
- Manufacturing Services
- Non-Clinical Services
- Research and Development
Global Pharmaceutical Contract Manufacturing Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- Rest of APAC
Rest of The World
- Latin America
- Middle East & Africa
Company Profiles
- Aenova Holding GmbH
- Ajinomoto Co., Inc.
- Almac Group Ltd.
- Amgen Inc.
- Aurobindo Pharma Ltd.
- Baxter International Inc.
- BDR Pharmaceuticals International Pvt. Ltd.
- BiologicsMD, Inc.
- Boehringer Ingelheim International GmbH
- Cadence Inc.
- Chunghwa Chemical & Pharmaceutical Co., Ltd.
- Ciron Drugs & Pharmaceuticals Pvt. Ltd.
- Confab Laboratories Inc.
- Daito Pharmaceutical Co., Ltd.
- Eli Lilly And Co.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline PLC
- Hisamitsu Pharmaceutical Co., Inc.,
- Ligand Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Novartis International AG
- Outlook Therapeutics, Inc.
- Pfizer Inc.
- PhytoHealth Corp.
- Piramal Enterprises Ltd.
- Procter & Gamble Co.
- Radius Health Inc.
- Sanofi S.A.
- Tarsa Therapeutics, Inc.
Teva Pharmaceuticals Industries Ltd.
Reasons for Buying from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pharmaceutical-contract-manufacturing-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
